Joseph Neal Sandy, CEO of Patient Care Solutions at GE HealthCare Technologies Inc., filed a Form 4 on November 18, 2026, disclosing the acquisition of restricted stock units and an employee stock option on November 16, 2026.

Key Highlights

  • RSU award: Joseph acquired 1,018 restricted stock units in GE HealthCare common stock at a price of $0 on November 16, 2026.
  • Stock option award: Joseph also received an employee stock option covering 2,589 shares of common stock at an exercise price of $82.96, expiring November 16, 2036.
  • Vesting schedule: Both the RSUs and the stock option vest in three tranches: 33% on September 1, 2027, 33% on September 1, 2028, and 34% on September 1, 2029.
  • Post-transaction ownership: Following the reported transactions, Joseph directly holds 4,798 shares of common stock and 2,589 derivative securities.
  • RSU settlement: According to the filing, each restricted stock unit represents the right to receive, at settlement, one share of GE HealthCare common stock.

RSU and Option Grants to GE HealthCare Patient Care Solutions CEO

The Form 4 filed with the SEC on November 18, 2026, covers transactions by Joseph Neal Sandy, who is identified in the filing as CEO, Patient Care Solutions at GE HealthCare Technologies Inc. (NASDAQ:GEHC). The filing reports two equity awards granted on November 16, 2026, both classified as acquisitions under transaction code "A."

The first award consists of 1,018 restricted stock units tied to GE HealthCare common stock, par value $0.01 per share, acquired at $0. According to the filing, 33% of these units will vest on September 1, 2027, 33% on September 1, 2028, and the remaining 34% on September 1, 2029. The filing states that each unit represents the right to receive one share of GE HealthCare common stock at settlement. Following this transaction, Joseph directly holds 4,798 shares of common stock.

The second award is an employee stock option granting the right to buy 2,589 shares of common stock at an exercise price of $82.96, with an expiration date of November 16, 2036. The filing notes the same three-tranche exercisability schedule: 33% becomes exercisable on September 1, 2027, 33% on September 1, 2028, and 34% on September 1, 2029. The option was acquired at a price of $0. The filing was signed by Frank R. Jimenez, General Counsel and Corporate Secretary, as attorney-in-fact, on November 18, 2026.

What Was Disclosed

The filing reports two equity awards granted to GE HealthCare's CEO of Patient Care Solutions on November 16, 2026: 1,018 restricted stock units and an employee stock option covering 2,589 shares at $82.96, both vesting across three installments through September 2029.